Moreover, the vitamin D analog, Maxacalcitol, significantly inhibits IMQ-induced psoriasiform dermatitis and reduces IL-17A mRNA expression in the skin, while also increasing Foxp3+ Treg cells (75). The gene discussed is IL17A; the disease is Psoriasiform dermatitis.